AU Patent

AU2014342520B2 — Novel treatments for attention and cognitive disorders, and for dementia associated with a neurodegenerative disorder

Assigned to Drexel University · Expires 2019-08-08 · 7y expired

What this patent protects

The present invention provides a method of treating or preventing an attention and/or cognitive disorder in a subject in need thereof, comprising administering to the subject a compound useful within the invention. The present invention further provides a method of treating or pr…

USPTO Abstract

The present invention provides a method of treating or preventing an attention and/or cognitive disorder in a subject in need thereof, comprising administering to the subject a compound useful within the invention. The present invention further provides a method of treating or preventing dementia associated with a neurodegenerative disorder in a subject in need thereof, comprising administering to the subject a compound useful within the invention.

Drugs covered by this patent

Patent Metadata

Patent number
AU2014342520B2
Jurisdiction
AU
Classification
Expires
2019-08-08
Drug substance claim
No
Drug product claim
No
Assignee
Drexel University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.